Global Agricultural Antibiotic Stewardship Accord: Binding Restrictions + Farmer Transition Fund
Description
A binding international accord — modeled on the Montreal Protocol for ozone and the CITES framework for endangered species — that phases out all non-therapeutic antibiotic use in livestock by 2030 in signatory nations, with a $50B Farmer Transition Fund to compensate farms for the loss of growth promotion benefits and support investment in alternative productivity gains (improved genetics, housing, feed efficiency).
5-1%) that are still produced for agriculture, creating a direct economic link between human medicine revenues and support for farmers transitioning away from growth promotion.
Implementation Pathway
Phase 1 (2025–2027)
- • Global accord negotiated and signed by G20 + African Union + ASEAN member states
- • Farmer Transition Fund capitalized at $50B
- • Mandatory antibiotic use registry operational
Phase 2 (2027–2031)
- • Phase-out of growth promotion antibiotics reaches 80% compliance in signatory states
- • Transition Fund deploying into farm-level productivity upgrades (genetics, housing, biosecurity)
- • Trade restrictions begin on non-compliant countries
Phase 3 (2031+)
- • 100% compliance with therapeutic-only antibiotic rules in signatory states
- • Global agricultural antibiotic use reduced by 60%
- • Human AMR prevalence decline of 15-30% attributable to agricultural restriction
Required Resources
Impact Analysis
Overall Net Impact
Combined analysis across all timeframes
Short-term
0-2 years
No benefits identified
No harms identified
Mid-term
3-10 years
No benefits identified
No harms identified
Long-term
10+ years
No benefits identified
No harms identified